Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preventing Tuberculosis-associated Immune Reconstitution Inflammatory Syndrome in High-risk Patients: a Randomized Placebo-controlled Trial of Prednisone

NCT01924286 is registered in ClinicalTrials.gov with University of Cape Town as lead sponsor.

NCT NCT01924286
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01924286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preventing Tuberculosis-associated Immune Reconstitution Inflammatory Syndrome in High-risk Patients: a Randomized Placebo-controlled Trial of Prednisone
Lead sponsor
University of Cape Town
Phase
Phase 3
Overall status
Completed
Start date
August 30, 2013
Completion date
April 30, 2017
Enrollment
240 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, immune reconstitution inflammatory syndrome, tuberculosis